vTv Therapeutics Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: vTv Therapeutics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: vTv Therapeutics Inc - Ordinary Shares - Class A
Rating: 1.12425
Author: Trendlyne DVM scores

about

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its p...

16.24 0.00 (0.00%)

39.81% Fall from 52W High

108

XNAS Volume

XNAS 29 Aug, 2025 4:01 PM (EDT)

Not Eligible

Expensive Valuation

4.5 / 100

Technically Neutral

40.5 / 100

1Yr Price target upside is 119%

2 analysts

vTv Therapeutics Inc - Ord... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

vTv Therapeutics Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its p...

39.81% Fall from 52W High

SWOT Analysis

vTv Therapeutics Inc - Ord... Live Price Chart